Improving Protection for Research Subjects
- 2 May 2002
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 346 (18) , 1425-1430
- https://doi.org/10.1056/nejm200205023461828
Abstract
In March 1996, Hoiyan Wan, a 19-year-old nursing student and a healthy volunteer in a study at the University of Rochester, died two days after undergoing bronchoscopy as part of the study. During the procedure, she received a fatal dose of lidocaine. A report that followed a state investigation criticized the researchers, the institutional review board (IRB), and the university.1 Wan's death led to many changes at the University of Rochester, including the establishment of training programs for investigators and an overhaul and expansion of the university's IRBs. The university's response is sometimes cited as a model for other institutions . . .Keywords
This publication has 6 references indexed in Scilit:
- IRB ReformNew England Journal of Medicine, 2002
- A Central Institutional Review Board for Multi-Institutional TrialsNew England Journal of Medicine, 2002
- Protecting Research Subjects — The Crisis at Johns HopkinsNew England Journal of Medicine, 2002
- Breaking the Camel's Back: Multicenter Clinical Trials and Local Institutional Review BoardsAnnals of Internal Medicine, 2001
- Protecting Research Subjects — What Must Be DoneNew England Journal of Medicine, 2000
- Is Academic Medicine for Sale?New England Journal of Medicine, 2000